| Hormonal Regulation and Hypertension | Lifetime | 92 | IT 4 | 99.42 |
| Blood Pressure and Hypertension Studies | Lifetime | 116 | IT 8 | 99.55 |
| Renin-Angiotensin System Studies | Lifetime | 50 | IT 2 | 99.15 |
| Heart Failure Treatment and Management | Lifetime | 167 | IT 10 | 99.35 |
| Heart Rate Variability and Autonomic Control | Lifetime | 256 | IT 21 | 98.93 |
| Sodium Intake and Health | Lifetime | 63 | IT 5 | 98.71 |
| Cardiovascular Function and Risk Factors | Lifetime | 599 | IT 36 | 98.95 |
| COVID-19 Clinical Research Studies | Lifetime | 926 | IT 109 | 96.97 |
| Cardiovascular Health and Disease Prevention | Lifetime | 450 | IT 30 | 97.89 |
| COVID-19 and healthcare impacts | Lifetime | 460 | IT 55 | 94.74 |
| Long-Term Effects of COVID-19 | Lifetime | 620 | IT 101 | 95.74 |
| GDF15 and Related Biomarkers | Lifetime | 58 | IT 1 | 95.89 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 268 | IT 20 | 97.36 |
| Lipoproteins and Cardiovascular Health | Lifetime | 555 | IT 21 | 97.75 |
| Cardiac Health and Mental Health | Lifetime | 511 | IT 12 | 96.77 |
| Pharmacology and Obesity Treatment | Lifetime | 345 | IT 31 | 96.31 |
| Potassium and Related Disorders | Lifetime | 219 | IT 11 | 95.82 |
| Medication Adherence and Compliance | Lifetime | 414 | IT 8 | 94.54 |
| Cardiovascular Health and Risk Factors | Lifetime | 862 | IT 15 | 90.47 |
| Cardiac Fibrosis and Remodeling | Lifetime | 915 | IT 22 | 90.15 |
| Takotsubo Cardiomyopathy and Associated Phenomena | Lifetime | 628 | IT 64 | 80.08 |
| Heart rate and cardiovascular health | Lifetime | 692 | IT 64 | 68.81 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 60 | IT 5 | 98.67 |
| Long-Term Effects of COVID-19 | 2021-2025 | 886 | IT 119 | 93.48 |
| Hormonal Regulation and Hypertension | 2021-2025 | 163 | IT 13 | 94.17 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 704 | IT 93 | 95.47 |
| Heart Failure Treatment and Management | 2021-2025 | 421 | IT 37 | 94.90 |
| Pharmacology and Obesity Treatment | 2021-2025 | 85 | IT 3 | 92.73 |
| Sodium Intake and Health | 2021-2025 | 102 | IT 7 | 90.88 |
| Cardiac Health and Mental Health | 2021-2025 | 626 | IT 27 | 85.84 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 913 | IT 80 | 85.97 |
| Renin-Angiotensin System Studies | 2021-2025 | 170 | IT 3 | 72.33 |
| Takotsubo Cardiomyopathy and Associated Phenomena | 2021-2025 | 236 | IT 45 | 69.63 |
| Gout, Hyperuricemia, Uric Acid | 2021-2025 | 785 | IT 55 | 67.09 |
| Chemotherapy-induced cardiotoxicity and mitigation | 2021-2025 | 994 | IT 63 | 67.12 |
| Eicosanoids and Hypertension Pharmacology | 2021-2025 | 606 | IT 34 | 64.09 |
